Clinical islet transplantation has recently received a the journal has made to the field as this new era for islet transplantation begins. strong impulse from the results obtained with the introduction of a glucocorticoid-free immunosuppressive reg-
The primary protocol of islet isolation was established more than a decade ago with the introduction of imen leading to insulin independence at 1 year in 100% of the treated patients. Thus, islet transplantation may the automated method. This method consists in loading the pancreas into a digestion chamber filled with collanow be considered as a viable routine option for the treatment of insulin-dependent diabetes mellitus. As an altergenase solution, and allowing for progressive islet release in a continuous digestion process. From that point native approach to endocrine cell replacement, it displays several potential advantages over whole-organ on, several modifications were adopted in order to improve islet recovery. The delivery of collagenase within transplant. Indeed, islet transplantation is at present a minimally invasive procedure and offers for the future the pancreas is performed by intraductal perfusion of the enzyme, allowing distension of the parenchymal tissue. the unique possibility of being performed under donorspecific tolerant conditions because islets may potenAppropriate diffusion of the collagenase solution from the ductal tree into the peri-islet interstitial matrix in a tially be engineered in vitro. In addition, various approaches such as in vitro islet expansion, the use of different portion of the gland depends on several factors, including perfusion pressure, temperature, time, and eximmortal beta cells, engineered surrogates, or xenogeneic islets could make the availability of donor tissues tracellular matrix composition. Several of these parameters are difficult to control or determine. This is the reaunlimited. However, most of these approaches are still to be realized in the clinical practice and several probson why Lakey et al. recently introduced a recirculating device system (10) that provides control over perfusion lems with the current procedure still need to be addressed to optimize certain aspects, such as organ propressures and collagenase temperature. With this procedure the enzyme solution is maintained cold (4°C) curement and preservation, islet isolation and culture, modality of transplant, and immunosuppression. Indeed, throughout the perfusion time and injection pressure is monitored and properly adjusted. The obtained results pancreata from multiple donors are still needed to guarantee a sufficient islet mass because a substantial numwere proved to be superior in terms of human islet recovery compared with standard retrograde injection usber of transplanted islets fails to engraft into the liver. Overcoming these obstacles may dramatically expand ing a syringe. Once isolated from the pancreas, islets can either be the number of transplants and even minor changes applied to the steps of the procedure may produce signifiimmediately transplanted or cultured for a defined period of time before the transplant. This latter approach cant impact in the short run. In light of the renewed enthusiasm in the field, the focus of the present update may provide several potential advantages over immediate transplant, such as the possibility to analyze the isis to review the articles published in Cell Transplantation since 1999 and to analyze the scientific contribution lets' functional capabilities, to further purify them from 310 BIANCONE AND RICORDI the exocrine contamination, or to manipulate them with most without exception, from cadaver organ donors. Despite any attempt to maximize the donors/recipients gene therapy tools. For these purposes, ideal culture conditions after isolation should at least replace the loss ratio in islet transplantation, the limited supply of organs will always represent a major obstacle for the diffusion of critical factors required for islet function and survival, most of which are still unknown. Several lines of reof this therapeutic approach for diabetes. This notion boosted the efforts to identify potential new sources of search involving different approaches stemmed from this notion. One approach is aimed at restoring the natuinsulin-producing cells that may act as surrogates for natural beta cells. A promising line of research stemmed ral extracellular interactions between islets and their microenvironment. It is well established that integrins, the from the observation that human pancreatic ductal cells may differentiate in vitro into insulin-producing cells. In surface receptors for extracellular matrix components, are able to transduce essential signals for cell function this respect, isolation and culture conditions are critical to generating an abundant ductal cell supply, as shown and survival. Indeed, several cell type-specific functions may be impaired in the absence of integrin-matrix interby Gmyr et al. (6) . Another strategy is aimed at genetically engineering cell lines with pro-insulin cDNA and action, because the intracellular domains of these receptors specifically interact with cytoskeleton components testing their ability to substitute for islet function. Indeed, pituitary GH3 cell clones transfected with human and influence its distribution within the cell. Furthermore, lack of integrin engagement may result in a spepro-insulin restored normoglycemia when transplanted in streptozotocin-treated mice (4). Concerns still remain cific apoptotic process, named "anoikosis," which affects tissue cells deprived of surface contact. In this as to the safety of transplanting immortalized/transformed cell lines and on the ability of non-beta cells to view, Nagata et al. attempted to reconstruct cell-collagen interaction in isolated rat islets (12). Indeed, they control insulin secretion. Current clinical islet transplantation protocols have were able to show that glucose-induced insulin secretion of islets cultured with collagen type I gel or a mixture selected the liver as the preferred site of islet implantation by direct delivery through the portal vein. Although of collagen type I and IV was improved after 11 days in culture. These results further underline the importance universally adopted, this option still has several pitfalls. Indeed, portal vein thrombosis still represents a serious of artificially preserving integrin-mediated signaling during islet culture as a tool for improving beta-cell complication during the islet transplant procedure. Moreover, several lines of evidence suggest that most transfunction and survival.
Recently, an improved in vitro culture media compoplanted islets are rapidly destroyed by an early nonspecific cell-mediated inflammatory injury response. In sition has been introduced for pretransplant preservation of human islets, allowing successful transplantation in fact, islets are forced to graft in an environment that is extremely reactive due to the abundancy of Kupffer patients with type I diabetes (1). In fact, there are now several patients at our institution and elsewhere who cells. This cell type possesses both proinflammatory activities and antigen-presenting capabilities. The interachave become insulin independent following transplantation of human islets cultured for 1-3 days on these contion of islets and acinar tissue with Kupffer cells has been explored by Clayton et al. in an in vitro coculture ditions before intraportal infusion.
Because the islet isolation procedure may induce relmodel (2). In this study, secretion of proinflammatory mediators such as thromboxane B 2 , prostaglandin E 2 , evant changes in islet behavior and viability, leading to direct consequences on the transplant outcome, sev-6-keto-prostaglandin F 1α , and prostaglandin F 2α by Kupffer cells was observed after coincubation with islets and eral investigators have focused on setting rapid, accurate, and objective measurements of islet viability after acinar tissue. These mediators participate in the inflammatory cascade that leads to the production of harmful isolation and culture. Indeed, Miyamoto et al. examined the features of fluorescein diacetate/ethidium bromide cytokines, such as TNF-α, and oxygen free radicals. Preventing the activation of this phenomenon is therestaining in viable cells and established a direct correlation between islets and their insulin content (11). In a fore of paramount importance in reducing the impact of primary nonfunction. Because the use of common antidifferent functional approach, Kanazawa et al. measured adenylylcyclase rat islet cell activity (7), because cAMP inflammatory agents, such as steroids, may be detrimental to islet function, the selective targeting of critical plays an essential role in determining islet beta-cell viability and responsiveness to various hormonal stimuli. molecules may represent an invaluable approach to counteract the inflammatory process. Blockade of TNF-α The correlation of the results with posttransplant islet cell function suggested that this assay is a valuable tool is of particular relevance due to its dual properties of inducing apoptosis of target cells and activating the into assess viability and perhaps efficiently predict islet transplant outcome. flammatory cells. Indeed, infection of human islets with an adenovirus construct encoding an inhibitor of TNF-α So far, transplanted islet tissue has been derived, al-
